Page 404 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 404

360               MEDICAMENTINDUISANTOUSTABILISANTDES COUPURES DE L'ADN


             STAHELIN H.F., Von WARTBURG A., From podophyllotoxin glucoside to etoposide,
               Prog. Drug Res., 1989, 33, 171-266.
             KETTENES-VAN DEN BOSCH J.J., HOLTHUIS J.J.M., BULT A., Teniposide, inAnalytical
               profiles of drug substance, Florey K., ed., Academic Press, New York, 1990, vol. 19,
               575-600.
             IMBERT T.F., Discovery of podophyllotoxins, Biochimie, 1998, 80, 207-222.

             VOIES D'ACCÈS
             KELLER-JUSLEN C., KUHN M., RENZ J., Von WARTBURG A., Epipodophyllotoxin Glu-
               coside Derivatives, U.S. Patent, 3, 524, 844, 1970.
             KELLER-JUSLEN C., KUHN M., Von WARTBURG A., Synthesis and Antimitotic Activity
               of Glycosidic Lignan Derivatives Related to Podophyllotoxin, J. Med. Chem., 1971,
               14, 936-940.
              Etoposide, Drugs of Future, 1979, 6, 257-261.
              SAULNIER M.G., LANGLEY D.R., KADOW J.F., SENTER P.D., KNIPE J.O., TUN M.M.,
               VYAS D.M., DOYLE T.W., Synthesis of etoposide phosphate. BMY-40481 a water-
               soluble clinically active prodrug of etoposide, Bioorg. Med. Chem. Lett., 1994, 4,
               2567-2572
              Etoposide Phosphate Disodium Salt, Drugs of Future, 1995, 20, 942-945.
              Etoposide Phosphate Disodium Salt, Drugs of Future, 1996, 21, 959-961.
              Etoposide Phosphate Disodium Salt, Drugs of Future, 2000, 25, 970.
              SIVELBERG  L.J.,  KELLY S.,  VEMISHETTI P.,  VIPOND  D.H.,  GISSON  F.S.,
                HARRISON B., SPECTOR R., DILLON J.L., A Crystallization-lnduced Stereoselective
                Glycosidation Reaction in the Synthesis of the Anticancer Drug Etoposide, Organic
                Letters, 2000, 2, 3281-3283.

              CARACTÈRES PHYSICOCHIMIQUES
              BREWER C.F., LOIKE J.D., HORWITZ S.B., Conformational Analysis of Podophyllotoxin
                and lts Congeners. Structure-Activity Relationship in Microtubule Assembly, d. Med.
                Chem., 1979, 22, 215-221.
              JARDINE 1., STRIFE R.J., KOZLOWSKI J., Synthesis, 470-MHz 'H NMR Spectra, and
                Activity of Delactonized Derivatives of the Anticancer Drug Etoposide, J. Med. Chem.,
                1982, 25, 1077-1081.
              HOLTHUIS J.J.M., VAN OORT W.J., ROEMKENS F.M.G.M., RENEMAJ., ZUMAN P.,
                Electrochemistry of podophyllotoxin derivatives. Part 1. Oxidation mechanism of eto-
                poside (VP 16-213), J. Electroanal. Chem. Interfacial Electrochem., 1985, 184, 317-
                329.
              HOLTHUIS J.J.M., VENDRIG D.E.M.M., VAN OORT W.J., ZUMAN P., Electrochemistry
                of podophyllotoxin derivatives. Part Il. Oxidation of teniposide and some epipodophyl-
                lotoxin derivatives, J. Electroanal. Chem. Interfacial Electrochem., 1987, 220, 101-
                124.
              ASO Y., HAYASHI Y., YOSHIOKA S., TAKEDA Y., KITA Y., NISHIMURA Y., ARATA Y,
                Epimerization and Hydrolysis of Etoposide Analogues in Aqueous Solution, Chem.
                Pharm. Bull., 1989, 37, 422-424.
   399   400   401   402   403   404   405   406   407   408   409